298 related articles for article (PubMed ID: 34503409)
1. Disease Burden and Current Therapeutical Status of Leprosy with Special Emphasis on Phytochemicals.
Swain SS; Sahoo G; Mahapatra PK; Panda SK
Curr Top Med Chem; 2022; 22(19):1611-1625. PubMed ID: 34503409
[TBL] [Abstract][Full Text] [Related]
2. Multiple docking analysis and
Halder ST; Dhorajiwala TM; Samant LR
Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of natural compounds on Dihydropteroate synthase of
Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
[TBL] [Abstract][Full Text] [Related]
5. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
Chaitanya V S; Das M; Bhat P; Ebenezer M
J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae.
Swain SS; Paidesetty SK; Dehury B; Das M; Vedithi SC; Padhy RN
Sci Rep; 2020 Apr; 10(1):6839. PubMed ID: 32322091
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
8. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Chakraborty A; Ghosh R; Biswas A
FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
[TBL] [Abstract][Full Text] [Related]
9. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
10. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Chhabra S; Narang T; Sahu S; Sharma K; Shilpa S; Sharma A; Jain S; Singh I; Yadav R; Kaur M; Sharma R; Nadeem M; Pandey P; Minz RW; Dogra S
J Glob Antimicrob Resist; 2023 Dec; 35():262-267. PubMed ID: 37852372
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
12. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
13. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
14. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
15. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
16. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
[TBL] [Abstract][Full Text] [Related]
18. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy.
Pinheiro LCS; Borges JC; Campos VR; Dantas LC
Mini Rev Med Chem; 2023; 23(4):497-512. PubMed ID: 35430972
[TBL] [Abstract][Full Text] [Related]
20. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
